FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132731324> ?p ?o ?g. }

• W3132731324 endingPage "160" @default.
• W3132731324 startingPage "151" @default.
• W3132731324 abstract "Inflammatory processes have been identified as key mediators of ischemia-reperfusion injury in ST-segment elevation myocardial infarction (STEMI). They add damage to the myocardium and are associated with clinical adverse events (heart failure and cardiovascular death) and poor myocardial recovery. Colchicine is a well-known alkaloid with potent anti-inflammatory properties. In a proof-of-concept phase II trial, colchicine has been associated with a significant 50% reduction of infarct size (assessed by creatine kinase levels) in comparison to placebo in acute STEMI patients referred for primary percutaneous coronary intervention (PPCI). The Colchicine in STEMI Patients Study (COVERT-MI) is an ongoing confirmative prospective, multicenter, randomized, double-blind trial testing whether a short course oral treatment with colchicine versus placebo decreases myocardial injury in patients presenting with STEMI referred for PPCI. Adult patients, with a first STEMI episode and an initial TIMI flow ≤1, referred for PPCI, will be randomized (<i>n</i> = 194) in a 1:1 ratio to receive an oral bolus of colchicine of 2 mg followed by 0.5 mg b.i.d. treatment during 5 days or matching placebo. The primary endpoint will be the reduction in infarct size as assessed by cardiac magnetic resonance at 5 ± 2 days between both groups. The main secondary endpoints will be tested between groups in hierarchical order with left ventricular ejection fraction at 5 days, microvascular obstruction presence at 5 days, and absolute adverse left ventricular remodeling between 5 days and 3 months. This academic study is being financed by a grant from the French Ministry of Health (PHRCN-16-0357). Results from this study will contribute to a better understanding of the complex pathophysiology underlying myocardial injury after STEMI. The present study describes the rationale, design, and methods of the trial." @default.
• W3132731324 created "2021-03-01" @default.
• W3132731324 creator A5000165273 @default.
• W3132731324 creator A5007043014 @default.
• W3132731324 creator A5011933171 @default.
• W3132731324 creator A5017437941 @default.
• W3132731324 creator A5022272687 @default.
• W3132731324 creator A5026930330 @default.
• W3132731324 creator A5029167438 @default.
• W3132731324 creator A5034823290 @default.
• W3132731324 creator A5034985469 @default.
• W3132731324 creator A5035015657 @default.
• W3132731324 creator A5039936186 @default.
• W3132731324 creator A5042601884 @default.
• W3132731324 creator A5051306204 @default.
• W3132731324 creator A5060434473 @default.
• W3132731324 creator A5066054410 @default.
• W3132731324 creator A5068622087 @default.
• W3132731324 creator A5072618260 @default.
• W3132731324 creator A5072876824 @default.
• W3132731324 creator A5083396561 @default.
• W3132731324 creator A5085577527 @default.
• W3132731324 creator A5087780620 @default.
• W3132731324 creator A5089586037 @default.
• W3132731324 date "2021-01-01" @default.
• W3132731324 modified "2023-10-18" @default.
• W3132731324 title "Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol – The COVERT-MI Study" @default.
• W3132731324 cites W1893844572 @default.
• W3132731324 cites W1999331329 @default.
• W3132731324 cites W2008845088 @default.
• W3132731324 cites W2008931703 @default.
• W3132731324 cites W2058474974 @default.
• W3132731324 cites W2066854825 @default.
• W3132731324 cites W2086430673 @default.
• W3132731324 cites W2097661629 @default.
• W3132731324 cites W2106853225 @default.
• W3132731324 cites W2111660499 @default.
• W3132731324 cites W2122256907 @default.
• W3132731324 cites W2174331910 @default.
• W3132731324 cites W2200357463 @default.
• W3132731324 cites W2317801401 @default.
• W3132731324 cites W2508059385 @default.
• W3132731324 cites W2590450973 @default.
• W3132731324 cites W2609319132 @default.
• W3132731324 cites W2799636782 @default.
• W3132731324 cites W2909785153 @default.
• W3132731324 cites W2986700515 @default.
• W3132731324 cites W3023400402 @default.
• W3132731324 cites W3024013989 @default.
• W3132731324 cites W4243146076 @default.
• W3132731324 doi "https://doi.org/10.1159/000512772" @default.
• W3132731324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33582664" @default.
• W3132731324 hasPublicationYear "2021" @default.
• W3132731324 type Work @default.
• W3132731324 sameAs 3132731324 @default.
• W3132731324 citedByCount "8" @default.
• W3132731324 countsByYear W31327313242021 @default.
• W3132731324 countsByYear W31327313242023 @default.
• W3132731324 crossrefType "journal-article" @default.
• W3132731324 hasAuthorship W3132731324A5000165273 @default.
• W3132731324 hasAuthorship W3132731324A5007043014 @default.
• W3132731324 hasAuthorship W3132731324A5011933171 @default.
• W3132731324 hasAuthorship W3132731324A5017437941 @default.
• W3132731324 hasAuthorship W3132731324A5022272687 @default.
• W3132731324 hasAuthorship W3132731324A5026930330 @default.
• W3132731324 hasAuthorship W3132731324A5029167438 @default.
• W3132731324 hasAuthorship W3132731324A5034823290 @default.
• W3132731324 hasAuthorship W3132731324A5034985469 @default.
• W3132731324 hasAuthorship W3132731324A5035015657 @default.
• W3132731324 hasAuthorship W3132731324A5039936186 @default.
• W3132731324 hasAuthorship W3132731324A5042601884 @default.
• W3132731324 hasAuthorship W3132731324A5051306204 @default.
• W3132731324 hasAuthorship W3132731324A5060434473 @default.
• W3132731324 hasAuthorship W3132731324A5066054410 @default.
• W3132731324 hasAuthorship W3132731324A5068622087 @default.
• W3132731324 hasAuthorship W3132731324A5072618260 @default.
• W3132731324 hasAuthorship W3132731324A5072876824 @default.
• W3132731324 hasAuthorship W3132731324A5083396561 @default.
• W3132731324 hasAuthorship W3132731324A5085577527 @default.
• W3132731324 hasAuthorship W3132731324A5087780620 @default.
• W3132731324 hasAuthorship W3132731324A5089586037 @default.
• W3132731324 hasBestOaLocation W31327313242 @default.
• W3132731324 hasConcept C126322002 @default.
• W3132731324 hasConcept C142724271 @default.
• W3132731324 hasConcept C164705383 @default.
• W3132731324 hasConcept C168563851 @default.
• W3132731324 hasConcept C203092338 @default.
• W3132731324 hasConcept C204787440 @default.
• W3132731324 hasConcept C27081682 @default.
• W3132731324 hasConcept C2777995511 @default.
• W3132731324 hasConcept C2778198053 @default.
• W3132731324 hasConcept C2780400711 @default.
• W3132731324 hasConcept C500558357 @default.
• W3132731324 hasConcept C71924100 @default.
• W3132731324 hasConcept C78085059 @default.
• W3132731324 hasConceptScore W3132731324C126322002 @default.
• W3132731324 hasConceptScore W3132731324C142724271 @default.
• W3132731324 hasConceptScore W3132731324C164705383 @default.

• next